Cargando…
Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
Autores principales: | Deltenre, Pierre, Moreno, Christophe, Trépo, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977066/ https://www.ncbi.nlm.nih.gov/pubmed/33753153 http://dx.doi.org/10.1016/j.jhep.2021.02.036 |
Ejemplares similares
-
Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”
por: Mallet, Vincent
Publicado: (2021) -
Intravenous ketamine and progressive cholangiopathy in COVID-19 patients
Publicado: (2021) -
Ketamine-induced cholangiopathy in ARDS patients
por: de Tymowski, Christian, et al.
Publicado: (2021) -
Persistent Ketamine-Induced Cholangiopathy: An Approach to Management
por: Nyirenda, Tiwonge J, et al.
Publicado: (2020) -
A rare case of eosinophilic cholangiopathy
por: Li, Wenya, et al.
Publicado: (2020)